Shibo Jiang, MD, PhD

Title

Member (RHP)

Research Area

Researches in the Laboratory of Viral Immunology are focused on the development of antiviral therapeutic agents and vaccines for the treatment and prevention of HIV infection/AIDS and other emerging and remerging infectious diseases caused by severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and influenza viruses, as well as the blood transfusion-related viruses, including zika virus (ZIKV) and West Nile virus (WNV).

Dr. Shibo Jiang is a pioneer in the field of viral fusion/entry inhibitors. His research focuses on development of therapeutics/vaccines against HIV, SARS-CoV, MERS-CoV, and avian influenza viruses. He has published 311 peer-reviewed papers, awarded 18 US patents, and served as editorial board members for 8 journals.

Contact Information

Email: SJiang@nybc.org
Phone: +1 (212) 570-3058

Lab

Viral Immunology

Lab Personnel

  • Shibo Jiang, M.D., Ph.D. Laboratory Co-Head
  • Lanying Du, Ph.D. Laboratory Co-Head
  • Wanbo Tai, M.Sc. Visiting Scientist, Ph.D. Student
  • Qianqian Qi, B.S. Visiting Scientist, Ph.D. Student
  • Yufei Wang, B.S. Visiting Scientist, M.Sc. Student
  • Min Li, Ph.D. Visiting Scientist
  • Songyi Ning, Ph.D. Visiting Scientist
  • Ron Rowe, B.S. Lab Assistant 

LIST OF PUBLICATIONS